3-Amino-4-cyanopyridine AND 1[s_discriminator] - dbGaP - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Search results

Items: 1 to 20 of 39

<< First< Prev

Page of 2

The following terms were not found in dbGaP: cyanopyridine, 3-Amino-4-cyanopyridine.

Search results: x Variables, w Analyses, x Documents, and z Datasets in x Studies

Studies (x)
Variables (y)
Study Documents (y)
Analyses (w)
Datasets (z)

Study	Embargo Release	Details	Participants	Type Of Study	Links	Platform
phs000280.v5.p1 Atherosclerosis Risk in Communities (ARIC) Cohort	Versions 1-5: passed embargo	V D AS	15678	Longitudinal, Cohort
phs000007.v30.p11 Framingham Cohort	Versions 1-30: passed embargo	V D AS	15154	Longitudinal		HuGeneFocused50K_Affy Mapping250K_Nsp Mapping250K_Sty Mapping50K_Hind240 Mapping50K_Xba240
phs000090.v4.p1 GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study	Versions 1-4: passed embargo	V D AS	12771	Case-Control		AFFY_6.0
phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	Versions 1-13: passed embargo	V D AS	8296	Longitudinal, Family	Links
phs000200.v12.p3 Women's Health Initiative	Versions 1-11: passed embargo Version 12:	V D AS	143213	Partial Factorial Randomized, Double-Blind, Placebo-Controlled, Cohort, Longitudinal	Links
phs000577.v1.p1 UCDC Longitudinal Study	Version 1: passed embargo	V D AS	542	Longitudinal	Links
phs000086.v3.p1 DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	Versions 1-3: passed embargo	V D AS	1497	Clinical Trial, Longitudinal	Links	HumanHap550v3.0 ILLUMINA_Human_1M
phs000343.v3.p1 The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	Versions 1-3: passed embargo	V D AS	2164	Multicenter, Randomized, Clinical Trial, Double-Blind, Controlled Trial		HumanOmni1-Quad_v1-0_B
phs000363.v17.p11 NHLBI Framingham SABRe CVD	Versions 1-17: passed embargo	V D AS	7558	Cohort		GeneChip Human Exon 1.0 ST Array Custom Panel TaqMan 350 MicroRNA Custom Panels
phs000001.v3.p1 NEI Age-Related Eye Disease Study (AREDS)	Versions 1-3: passed embargo	V D AS	4757	Case-Control	Links	ILMN_Human-1 Mapping50K_Hind240 Mapping50K_Xba240
phs000309.v3.p2 The CARDIA-GENEVA Study	Versions 1-3: passed embargo	V D AS	1926	Longitudinal	Links	AFFY_6.0
phs000592.v1.p1 Screening Protocol and Longitudinal Study of Bone Marrow Failure Syndromes and Cytopenias	Version 1: passed embargo	V D AS	341	Longitudinal, Prospective	Links
phs000236.v2.p2 PAGE: CALiCo: Coronary Artery Risk Development in Young Adults(CARDIA)	Versions 1-2: passed embargo	V D AS	3595	Longitudinal	Links	TaqMan OpenArrays: CALiCo ABD TaqMan Y1 TaqMan OpenArrays: CALiCo ABD TaqMan Y2 TaqMan OpenArrays: CALiCo AOD TaqMan Y1 TaqMan OpenArrays: CALiCo AOD TaqMan Y2 TaqMan OpenArrays: CALiCo DME TaqMan Y1 TaqMan OpenArrays: CALiCo DME TaqMan Y2 TaqMan OpenArrays: CALiCo Sequenom Y2 iSelect Custom Panel
phs000378.v1.p1 Indianapolis-Ibadan, Nigeria Comparative Epidemiological Study of Dementia	Version 1: passed embargo	V D AS	1251	Community, Longitudinal, Cross-Sectional	Links	HumanOmni2.5
phs000605.v1.p1 Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus Trial (The MILES Trial)	Version 1: passed embargo	V D AS	111	Clinical Trial, Clinical Diagnostic Testing, Randomized Controlled Clinical Trial	Links
phs000018.v2.p1 Search for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes (GoKinD study participants), GAIN	Versions 1-2: passed embargo	V D AS	1972	Case-Control	Links	Mapping250K_Nsp Mapping250K_Sty
phs000088.v1.p1 Search for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes (GoKinD study participants and parents), NIDDK	Version 1: passed embargo	V D AS	1206	Case-Control	Links	Mapping250K_Nsp Mapping250K_Sty
phs001073.v1.p1 Epigenetic Analysis of Malnutrition	Version 1: passed embargo	V D A S	59	Interventional, Randomized, Clinical Trial		TruSeq ChIP
phs000888.v1.p1 eMERGE Network Imputed GWAS for 41 phenotypes	Version 1: passed embargo	V D AS	55029	Case-Control, Cohort	Links	1000 Genomes
phs000521.v1.p1 Episodic Ataxia Syndrome	Version 1: passed embargo	V D AS	131	Longitudinal

<< First< Prev

Page of 2

Supplemental Content

Filter your results:

Manage Filters

Find related data

Recent activity

Clear Turn Off Turn On

3-Amino-4-cyanopyridine AND 1[s_discriminator] (39)
dbGaP
Mus musculus prostaglandin reductase 2 (Ptgr2), transcript variant 2, mRNA
Mus musculus prostaglandin reductase 2 (Ptgr2), transcript variant 2, mRNA
gi|357933644|ref|NM_001252625.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Getting Started

Important Links